Photo Credit: by Karolina Grabowska, Pexels.com
As we continue to endure more than two years of the novel coronavirus pandemic, there is more hope on the horizon as researchers have discovered that a new diabetes drug may be able to reduce mortality in COVID-19 infections. Rybelsus is a prescription drug available from Canadian Pharmacy World and other drug dispensaries, which may lessen the overall risk of severe COVID-19 outcomes.
In 2019, the U.S. Food and Drug Administration (FDA) approved Rybelsus (semaglutide) tablets in strengths of 7 mg or 14 mg for adults with type 2 diabetes. Along with diet and exercise, the research found that these tablets may improve blood sugar, or glucose, for those who require an antidiabetic treatment.
Of course, any new diabetes drug is a big deal for those in the market for diabetes medications. A release from Novo Nordisk explains it this way: “Type 2 diabetes is a global public health issue that impacts more than 28 million people in the U.S. alone. Despite existing treatment options, many adults with type 2 diabetes have poorly managed blood sugar that can increase the risk of developing serious diabetes-related complications.”
That’s why it’s important for more and more medications like Rybelsus and Jardiance, another top diabetes product, to hit the market and improve the lives of those with diabetes.
However, there’s another reason that diabetes drugs are important in the COVID-19 pandemic era. A study that examined the impact of diabetes on COVID-19 mortality and hospital outcomes explains: “To date, COVID-19 has claimed 4.9 million lives. Diabetes has been identified as an independent risk factor of serious outcomes in people with COVID-19 infection. … diabetes constitutes a poor prognosticator for various COVID-19 infection outcomes.”
In other words, those with diabetes are at higher risk of poor outcomes from COVID-19 infection. Diabetes has a negative impact on COVID-19 outcomes, but drugs like Rybelsus may lessen the risk of severe outcomes and fatality.
Penn State College of Medicine researchers found: “A type of drug already used to treat obesity and Type 2 diabetes, when taken six months prior to the diagnosis of COVID-19, was associated with a decreased risk of hospitalization, respiratory complications and death in COVID-19 patients with Type 2 diabetes.”
The drug they are describing is a class of medicines known as glucagon-like peptide-1 receptor (GLP-1R) agonists, and Rybelsus belongs to this class. What exactly does Rybelsus do? It helps your body to make insulin when your blood sugar is high. Researchers are working hard to find the scientific explanation behind why this drug seems to have the power to reduce severe COVID-19 outcomes.
While Rybelsus is not a cure for COVID-19, the results we are seeing so far in preventing severe outcomes for diabetic patients is promising. As more research is conducted, scientists will continue to explore the link between various medications and their ability to prevent fatalities from COVID-19. By keeping diabetic patients healthy, we can prevent higher rates of mortality from COVID-19.
Acquiring Rybelsus and other drugs is easier than ever in the age of the Internet. Canadian Pharmacy World is a verified online Canadian pharmacy that enables customers to get your prescriptions easier. With the proper prescription from a doctor, drugs like Rybelsus can be mailed directly to your door and the pharmacy even offers free shipping which not only means you don’t have to take a trip to the pharmacy, but you don’t even have to leave your house. You can buy Rybelsus online with a few simple clicks of a button. Use Rybelsus coupon code “RYB15” to place an order and save $15.00. (one-time use only). Always consult your doctor before taking any diabetes medications. A prescription from your healthcare professional is required to order Rybelsus and all other prescription medications.
As more is discovered about how to reduce complications and severe outcomes of COVID-19, we will continue to see drugs like Rybelsus involved in the fight against COVID-19 mortality rates.
Your email address will not be published. Required fields are marked with *.